| Q37497599 | An FMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia |
| Q35839390 | Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. |
| Q34370994 | Cognition in schizophrenia |
| Q44368428 | Cognitive disparity in schizophrenics with and without cocaine dependency |
| Q47945952 | Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls |
| Q48449814 | Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q36727032 | Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status |
| Q37285509 | Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis |
| Q39517216 | Executive functioning in individuals with schizophrenia and/or cocaine dependence. |
| Q43872699 | Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings. |
| Q37421576 | Neurocognitive characteristics of individuals with schizophrenia and cocaine dependence: comparison of currently dependent and remitted groups |
| Q33762494 | Neurocognitive functioning of individuals with schizophrenia: using and not using drugs |
| Q37149014 | The effectiveness of treatments for cocaine dependence in schizophrenic patients: a systematic review. |
| Q36965847 | The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues |
| Q51952571 | Working memory and depressive symptoms in patients with schizophrenia and substance use disorders. |